Silony Medical completes acquisition of Centinel Spine’s Global Fusion Business

8336

Silony Medical has announced that it has completed the acquisition of Centinel Spine’s Global Fusion Business and related assets.

The completed transaction includes all of Centinel’s cervical and lumbar fusion products, including the STALIF technology platform. These products will now be combined with Silony’s Verticale posterior screw and rod fusion platform, as well as its Roccia and Favo interbody fusion (IBF) systems, to create a “first-in-class” portfolio for both open and minimally invasive spinal fusion cases, as per a Silony press release.

Silony has been active in the US market since late 2018 and, with this acquisition, now plans to capitalise on the “great team and distribution network of the Centinel Fusion Portfolio” to strengthen its position in the North American spine market. This acquisition also “significantly strengthens” the company’s anterior standalone cage offering, the release adds.

In the coming days and months, Silony will change its name to Silony Spine to “underscore its 100% commitment and focus” on spine fusion technology solutions. Simultaneously, it will begin a refresh of the STALIF platform to drive further adoption among the spine surgeon community, and will soon thereafter launch its next generation of technology-enabled instruments.

Announcing this divestment of its Spine Fusion Business, Centinel notes in a separate press release that it will now focus exclusively on its Prodisc total disc replacement (TDR) business, and on attaining the number one global cervical/lumbar TDR market position in the near term.

“Today, Centinel Spine begins a new era—one of full focus, commitment, and action towards improving patients’ lives through spine motion preservation,” said Centinel CEO Steve Murray. “The outstanding long-term clinical evidence of patient benefit with the Prodisc disc replacement platform in an under-served, high-growth market uniquely positions us to make a real difference in spine care around the world. We are pleased to know that the STALIF fusion portfolio we have sold to Silony Spine will be taken forward by their committed, dynamic and expert team.”

The terms of this previously announced agreement between Silony and Centinel were not disclosed.


LEAVE A REPLY

Please enter your comment!
Please enter your name here